MRD updates in multiple myeloma at ASH 2021 Faith Davies, MBBCh, MRCP, MD, FRCPath, NYU Langone Medical Center, New York, NY, provides updates in the field of minimal residual disease (MRD) testing in multiple myeloma, including studies assessing the MRD status of patients receiving daratumumab at different points in time, as well as data linking […]

Read More